Comparative study between 3D-QSAR and Docking-Based Pharmacophore models for potent Plasomodium falciparum dihydroorotate dehydrogenase inhibitors. Issue 2 (15th January 2016)
- Record Type:
- Journal Article
- Title:
- Comparative study between 3D-QSAR and Docking-Based Pharmacophore models for potent Plasomodium falciparum dihydroorotate dehydrogenase inhibitors. Issue 2 (15th January 2016)
- Main Title:
- Comparative study between 3D-QSAR and Docking-Based Pharmacophore models for potent Plasomodium falciparum dihydroorotate dehydrogenase inhibitors
- Authors:
- Tseng, Tien-Sheng
Lee, Yu-Ching
Hsiao, Nai-Wan
Liu, Yun-Ru
Tsai, Keng-Chang - Abstract:
- Graphical abstract: The pharmacophore mapped conformation of the test compound NO.65 (equal ensemble of A26) is well-overlapped with the A26 inhibitor of Pf DOHDH complex structure (PDB ID:1TV5 ), rmsd = 0.475. Abstract: Malaria, caused by infections of the human malaria parasites Plasmodium falciparum, is a global infectious parasitic disease. Each year, about three million people died from malaria and the majority of whom are pregnant women and young children. Recently, a number of research attempt to reduce malaria parasite resistance and the toxicity of anti-malarial drugs. Nowadays, Plasmodium falciparum dihydroorotate dehydrogenase ( Pf DHODH) was validated as a potent drug target to inhibit malarial activity by blocking pyrimidine biosynthesis. In this study, we employed 3D-QSAR Pharmacophore Generation and Docking-Based Pharmacophore Development to build the pharmacophore by using the collected 67 effective inhibitors against Pf DHODH. 3D-QSAR Pharmacophore model, Hypo1, shows the high correlation coefficient (0.935), the lowest RMS deviation (2.15), the predicting accuracy of successful rates to training set (89.4%) and test set compounds (72.4%), respectively, revealing favorable predictive ability and is a reliable for further study. Additionally, Docking-Based Pharmacophore model, DBP-All255, exhibits comparable predictive capability to that of Hypo1, while DBP-Top1 shows poor statistical significance. This study reveals pharmacophore features of Hypo1, built byGraphical abstract: The pharmacophore mapped conformation of the test compound NO.65 (equal ensemble of A26) is well-overlapped with the A26 inhibitor of Pf DOHDH complex structure (PDB ID:1TV5 ), rmsd = 0.475. Abstract: Malaria, caused by infections of the human malaria parasites Plasmodium falciparum, is a global infectious parasitic disease. Each year, about three million people died from malaria and the majority of whom are pregnant women and young children. Recently, a number of research attempt to reduce malaria parasite resistance and the toxicity of anti-malarial drugs. Nowadays, Plasmodium falciparum dihydroorotate dehydrogenase ( Pf DHODH) was validated as a potent drug target to inhibit malarial activity by blocking pyrimidine biosynthesis. In this study, we employed 3D-QSAR Pharmacophore Generation and Docking-Based Pharmacophore Development to build the pharmacophore by using the collected 67 effective inhibitors against Pf DHODH. 3D-QSAR Pharmacophore model, Hypo1, shows the high correlation coefficient (0.935), the lowest RMS deviation (2.15), the predicting accuracy of successful rates to training set (89.4%) and test set compounds (72.4%), respectively, revealing favorable predictive ability and is a reliable for further study. Additionally, Docking-Based Pharmacophore model, DBP-All255, exhibits comparable predictive capability to that of Hypo1, while DBP-Top1 shows poor statistical significance. This study reveals pharmacophore features of Hypo1, built by 3D-QSAR Pharmacophore Generation, are well-complementary to the functional residues in the active site of Pf DHODH and is of great reliable for database screening. … (more)
- Is Part Of:
- Bioorganic & medicinal chemistry letters. Volume 26:Issue 2(2016)
- Journal:
- Bioorganic & medicinal chemistry letters
- Issue:
- Volume 26:Issue 2(2016)
- Issue Display:
- Volume 26, Issue 2 (2016)
- Year:
- 2016
- Volume:
- 26
- Issue:
- 2
- Issue Sort Value:
- 2016-0026-0002-0000
- Page Start:
- 265
- Page End:
- 271
- Publication Date:
- 2016-01-15
- Subjects:
- Pharmacophore -- PfDHODH inhibitor -- Catalyst -- 3D-QSAR Pharmacophore Generation -- Docking-Based Pharmacophore Development
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
572 - Journal URLs:
- http://www.elsevier.com/wps/find/journaldescription.cws_home/972/description#description ↗
http://www.sciencedirect.com/science/journal/0960894X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmcl.2015.12.043 ↗
- Languages:
- English
- ISSNs:
- 0960-894X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.330000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 7741.xml